Lamprene

Lamprene containing Clofazimine is an antimycobacterial drug used in combination with other agents for the treatment of leprosy. It also has anti-inflammatory properties that help control erythema nodosum leprosum reactions.

Dosage by Body Weight

Should be taken with meals or milk to improve absorption. The dosage must be individualized by a physician based on the severity of the disease and patient response.

  1. Body Weight
    Below 5 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and efficacy have not been established for infants in this weight range.
  2. Body Weight
    5-7 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Generally not recommended for infants in this weight range unless specifically directed by a specialist.
  3. Body Weight
    8-10 kg
    Dose
    Consult specialist
    Frequency
    As directed by physician
    Tracking Notes
    Use only if the potential benefits outweigh the risks; dosage must be carefully calculated.
  4. Body Weight
    11-15 kg
    Dose
    50 mg
    Frequency
    Once every other day or twice a week
    Tracking Notes
    Must be administered under strict medical supervision and taken with food.
  5. Body Weight
    16-20 kg
    Dose
    50 mg
    Frequency
    Once every other day or three times a week
    Tracking Notes
    Must be taken with food. Adjust dosage based on clinical response and tolerability.

Formulation

Capsule

Purpose

Treatment of lepromatous leprosy (including dapsone-resistant leprosy) and erythema nodosum leprosum.

Generic Name

Clofazimine

Scheduled Drug

Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.

Alternatives

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.